IP Offerings Logo

Patent MarketPlace: Medical Electronic and Device Patents for Sale

Temporary Access and Closure for Cardiac Surgery (Milo): U.S. Patent No. 9,610,097 and European Patent 2747679

About 500,000 Americans undergo open heart surgery in the U.S. each year. This involves the surgeon accessing the ventricle of the heart while a heart-lung machine takes over the patient’s cardiac and respiratory functions. Time is critical. The surgeon needs to be in and out as soon as possible so the patient can resume his or her own heart and lung functions. However, doing surgery on a beating heart eliminates the need for a heart-lung machine. This approach is usually done through the apex of the heart, but carries complications such as muscle tearing, massive bleeding, and – possibly – death. Introduction of larger devices or implants, or instruments, is not practical.

This patent family creates a device that provides temporary access to the ventricle of the heart and then closes the access passage when the surgery is completed – without the loss of even one drop of blood! The device includes an anchor with a wire spiral for implantation in the tissue wall of the heart and a handle that is detachably connected to the anchor. The handle provides an axial passageway in which a hollow needle is received. With the anchor in juxtaposition with the apex of the heart, the pointed end of the hollow needle is inserted into the ventricle. With its presence traversing the wall of the heart, it provides a stable axis about which the wire spiral can be rotated to seat the anchor in precise circumscribing fashion about the hollow needle. Once the implant carrying device has completed its function, it is retracted outward while the spiral anchor is rotated deeper into the muscle closing the penetration point in the apex. Reconstruction of the contour of the apex is then completed. This technology also enables the introduction through this anchor of devices or implants of far larger sizes than common cardiac catheters. All this is done without tearing the heart and without losing a single drop of blood. The device can be removed and used again.

U.S. Patent No. 9,610,097 and European Patent 2747679 for a “Device for creating temporary access and then closure” will enable any surgical equipment supplier to introduce a new product that will dramatically aid heart surgeons who need to enter the ventricle of the heart.

Advanced Cardiac Surgery Stapler (QuickRing): U.S. Patent No. 10,278,695

Over 900,000 cardiac surgeries were performed in the U.S. last year. And that number will grow as the population ages. One of the challenges facing cardiac surgeons is to use the “transapical” approach, perform surgery on a beating heart, or connect the patient to a heart-lung machine and have it take over the work of the heart. Whenever possible, surgeons will attempt a minimally invasive approach since it is less risky and less trauma for the patient.

This patent creates an advanced surgical stapler that is especially designed for the use inside the heart. It can be introduced into the heart while the heart is beating, avoiding having to connect the patient to a heart-lung machine. This advanced stapler can be used in open heart surgery as well as in minimally invasive procedures. All possible angles, including rotation of its firing parts, are all guided from its handle which always remains in the hand of the surgeon. It is also designed to work "backwards" – in fact, in any desired angle based on the needs of the surgeon. This advanced surgical stapler is self-loading so it does not have to be removed from inside the heart to be reloaded with staples.

U.S. Patent No. 10,278,695 for a “Surgical stapler” will enable any surgical equipment manufacturer to introduce a stapler that leapfrogs with technology of all its competitors!

Mitral and Tricuspid Valve Repair Rings (QuickRing): U.S. Patent No 8,349,002

About one million Americans undergo heart surgery a year, and that number will continue to grow steadily as the population ages. The good news is that heart surgery most often produces excellent results! Cardiac surgery often includes replacement of the mitral or tricuspid valve, and when that is done, the surgeon may need to implant an annuloplasty ring that restores the shape and tightens the ring – known as an annulus – around the valve. An accurate fit of the annuloplasty ring is critical to successful valve repair! This patent addresses that need by creating an annuloplasty ring that is composed of two separate parts that are adjustably interconnected to create a ring that can be easily changed in circumference. The rings covered by this patent allow bidirectional movement to either shorten or lengthen the ring, giving the surgeon the opportunity to make further adjustments to the diameter of the annuloplasty ring after it is initially secured to the heart valve that is being repaired. The mating interconnections at two lateral locations on the ring can be constructed to allow hinged movement between the two halves, making it easier for the surgeon to adjust the ring to the optimal diameter and shape. U.S. Patent No. 8,349,002 for “Adjustable annuloplasty rings” would enable any surgical equipment supplier to leapfrog the technology of all of its competitors and offer a next-generation annuloplasty ring. This is a foundational patent with 63 Forward Citations.

Face Mask that Sterilizes Incoming and Outgoing Air (Brady): U.S. Patent No. 11,219,255

In a post-pandemic world, we are all more aware than ever of the possibility of another outbreak that could close schools, businesses, and borders with devastating consequences. Emergency and medical workers will need to be protected from the next airborne bacterial or viral infection, and that means disinfecting the air they breathe when treating those infected with airborne pathogens.

Whether it is another variant, a new mutation, or a biohazard situation, this patent creates a protective face mask that filters the incoming (or exhalent) infected air. This device is a portable, battery-operated breathing apparatus that offers broad-spectrum antimicrobial and allergen protection using a safe biocidal agent in conjunction with filtration to purify incoming and outgoing air. The mask combines hydrogen peroxide, as a liquid, steam or vapor, with iodized salt in a hydrophilic filter. This mask sterilizes incoming and exhaled air by capturing, neutralizing, and destroying airborne pathogens and other particulate matter and then replacing the infected air with sterilized oxygen or air for natural, unlabored breathing by the wearer.

U.S. Patent No. 11,219,255 for a “Self-contained, mobile breathing apparatus or appliance that supplies pathogen and endotoxin free, rhythmically breathable air to the wearer or treated space through active, continuous bio-deactivation and destruction of bacteria, fungi, viral and allergenic/antigenic matter safely when using benign, household, rechargeable filtration media” will enable any medical electronics manufacturer to introduce the next-generation in hazmat protection for emergency and medical personnel.

Next-Generation Patient Stretcher (Viveros): U.S. Patent No. 11,013,645

The injured have been transported on stretchers for literally hundreds of years. They originally used wooden poles across which canvass or another material was stretched. Today the frames of most stretchers are aluminum because it is strong and lightweight. Other than replacing the wooden poles with aluminum poles, not many improvements have been made to the emergency stretcher.

This patent changes all that by creating what is truly a next-generation stretcher. There are injuries that call for the patient’s legs to be elevated, or for special protection for the cervical or lumbar spine, but the current generation of stretchers cannot address that need – all they can do is carry the patient on a flat surface or prop up the head and shoulders of the patient. This new and improved stretcher has hinged, locking arms that permit the emergency personnel to quickly and easily raise a section of the stretcher to the optimum height and lock it in place so it supports the patient’s legs. Additionally, the lightweight plastic and other materials used to manufacture the stretcher allows it to be directly transferred from ambulances to radiography equipment, CT scanners, MRI machines, or operating rooms without the need to move the patient to another stretcher, improving efficiency and reducing the risk of further injury.

U.S. Patent No. 11,013,645 for an “Emergency stretcher” will enable any emergency equipment or medical products manufacturer to leapfrog the technology of all of its competitors and offer a stretcher with this important, added capability.

Bandage for Fingers and Deep Lacerations (J&C Medical): Australian Patent and U.S. and PCT Patent Applications

Adhesive bandages have been around for just over 100 years, and they are ideal for treating minor cuts and scrapes. However, the current generation of adhesive bandages have two shortcomings: They are not effective at bandaging fingers or deep lacerations.

This patent family covers a bandage with an extra pair of cross arms. In addition to two traditional adhesive strips that hold the bandage in place, there are two addition adhesive strips that extend out like two fingers. One set of strips holds the bandage in place vertically while the second set of cross arms hold the bandage in place horizontally. In the case of a finger, they wrap around the finger to hold the bandage securely in place. The result is a bandage that protects the wound from infection and also keeps a cut closed tightly so it can heal more quickly. In fact, for lacerations that might require stitches to close them, this bandage can be used by first aid crews to temporarily hold a deep wound closed until the patient can be taken to a medical facility. For wounds that are down to only the subcutaneous layer, this bandage may be used as a primary closure. One variation of the invention includes embedding an antibiotic in the adhesive to further prevent infection. Also, the patent’s design is totally scalable, allowing for bandages of multiple sizes and shapes.

U.S. Patent Application 20220362064 and Australian Patent 2022259762 for an “Adhesive wound dressing and method of application thereof for dressing lacerations” will enable any bandage manufacturer to introduce the next generation of adhesive bandages for both consumer and professional use. And the PCT Patent Application will permit the acquirer of this patent family to apply for additional national patents around the world.

Bed with Toileting Capability: U.S. Patent No. 10,849,805 and Continuation

Toileting issues for the bed-bound or mobility-limited are an everyday challenge. Whether recovering from an illness or injury, or suffering from a long-term condition with limited mobility – at home, in a hospital, or other healthcare facility – toileting is an everyday, multiple-time occurrence. And that means either waiting for assistance getting out of bed and traveling to and from the bathroom, or using a bed pan, diapers, or catheter. None are an attractive, convenient, or practical option!

This patent creates a bed that allows its user to both urinate and have a bowel movement without leaving the bed. The mattress and frame of the bed include a cut-out opening that houses a waste container that permits the user to urinate or defecate. The waste drops into the container beneath the bed which can then be pulled out using a drawer system and easily removed for cleaning and replacement. Depending on health stage and capabilities, the user can remove a sealed container cover, slide over to use the container, clean himself or herself, and then replace the cover sealing in the odors. If the user is non-mobile and cognizant, he or she can lie directly over the custom filter padded container in open-back wear and eliminate as necessary. Waste will filter down away from the patient into a container which can be cleaned by a caregiver at a later time.

This bed spares the user the inconvenience and danger of using a walker, possibly falling, or having to wait for the assistance of a caregiver. The modular design allows for easy cleaning and hygiene maintenance as well as ease of replacement of components and assembly. U.S. Patent No. 10,849,805 and U.S. Patent Application 20210106477 for a “Bed” would enable any manufacturer of equipment for the healthcare industry to offer a specialized bed to meet the needs of bed-ridden or mobility-limited patients for in-home care as well as hospitals and other health care facilities.

SmartWatch and Medical Monitoring Device (Bouyahia and Kerrouche): U.S. and European Patents and PCT Patent Application

It’s easy to check your oxygen level, heart rate, and blood flow. Just call up your family physician, make an appointment, take time off from work, drive to your physician’s office, wait in the waiting room, be tested by a medical assistant, wait again to see your doctor, and get the results. Okay. Maybe not so easy. There must be a way to check your vital signs at any time without all the fuss.

There is. This portfolio covers a smartwatch that – in addition to providing you with the time and other data – passively monitors your oxygen level, heart rate, and blood flow. It includes a measurement instrument positioned opposite the radial artery of the smartwatch owner’s wrist that includes sensors that continuously measure the oxygen level, heart rate, and ascending and descending blood flow. A processor in the watch collects data from the three sensors, analyzes the data, and stores it for download by the watch owner.

Patent and Application Portfolio

The acquirer of this portfolio will be able to introduce the first smartwatch with medical monitoring capabilities, and the PCT Application enables the acquirer to apply for additional national patents anywhere in the world!

Extraction of Stem Cells from Adipose Tissue (Mystem): U.S. and European Patents

Stem cells have become a critical element in the treatment of many diseases and afflictions. Stem cells are the body's raw materials — cells from which all other cells with specialized functions are generated. Under the right conditions in the body or a laboratory, stem cells divide to form more cells called “daughter cells.” These daughter cells become either new stem cells or specialized cells with a more specific function. No other cell from the human body has the ability to generate new cell types.

However, harvesting regenerative cells for transplantation has been a challenge. The technology covered by this portfolio enables a surgeon to remove, concentrate, and re-administer the regenerative cells – and put them to work improving the healing process – in just minutes! The technology allows surgeons to obtain an autologous graft fraction that is rich in regenerative components. The portfolio creates a disposable kit that performs single-step, intra-OR, autologous, minimal tissue manipulation. Using this patented technology, it only takes about 10 minutes from harvesting to regenerative fraction final product. Currently, the most often used stromal tissues for regenerative purposes are bone marrow and adipose tissue. This portfolio creates a Class IIA medical device for autologous stromal tissue graft fractioning.

This portfolio consists of U.S. Patent No. 10,246,683 and European Patent 3174973 for a “Method and assembly for extraction of regenerative cellular components from adipose tissue.” This portfolio would be a strategic acquisition for any business that is currently supplying regenerative products or biomaterials or is prepared to enter this high-growth market segment.

4D Ultrasound Imaging (Elbe): U.S. and European Patents

Physicians need to see inside the human body to accurately diagnose many diseases, injuries, and infections. CT (computed tomography) scans are popular, but a CT scan bombards the body with radiation. While small doses of radiation are harmless, the accumulated effect of radiation from CT scans and other sources – such as dental X-rays, chest X-rays, and flying, as well as exposure to products that emit radiation – can result in an unhealthy level of radiation for many people.

Ultrasonic technology uses no radiation, so it is clearly the safest method for viewing into the insides of the human body. But the current generation of 4D ultrasonic technology can only view a small area and is used primarily for viewing fetuses (because it is safe) during pregnancy. The term “4D” refers to not just a 3D image – height, width, and depth – but a moving video image such as a baby in the womb. What is clearly needed for physicians to see into the insides of their patients, and do so without the use of radiation, is a 4D ultrasonic technology that can capture video of any part of the body – or the entire human body – for any given period of time. That is the technology covered by this patent portfolio!

This portfolio covers a technology for viewing the inside of the human body (or an animal's body or the inside of inanimate devices) using a network of Ultrasonic Detection Modules (UDMs) that are assembled into an Ultrasonic Detection Assembly (UDA) that surrounds the area to be viewed. For a human, this would be a suit that has UDMs placed throughout it, and while the patient is wearing this UDA suit, his or her body is being viewed by ultrasonic waves from the UMDs that feed data back to a central unit that creates a 4D video image of the patient's insides! This technology has applications in Sports Medicine because a physician can view the patient's organs while the patient is in motion – even running or jumping.

This portfolio will enable a medical device manufacturer to bring to market a highly effective and very affordable 4D imaging product line that will compete very favorably against both CT and MRI technologies in terms of performance and cost. The portfolio includes U.S. Patent No. 11,026,692 for a “Device and system for restricting fluid flow in physiological vessels” and European Patent Application 3426167 for a “Device and system for restricting fluid flow in physiological vessels.”

Next-Generation Surgical Foot Pedal Controls (Innovation Lab): U.S. Patent No. 11,134,775

Today, a surgeon must possess highly developed hand-foot-eye coordination as more and more surgical equipment adds foot controls. Microsurgery, microvascular surgery, neurology, laparoscopy, orthopedic and endoscopy surgery, and ear, nose, and throat surgeries often utilize surgical equipment with both hand and foot controls. These create quite a challenge for the surgeon who has to quickly determine which foot pedal does what, and the surgeon has to make sure that the pedals do not move from where they are supposed to be so they are not activated accidentally.

This patent covers technology that takes foot pedal controls to the next level of convenience and performance. It accommodates multiple pedals, it uses a weighted device with a tacky bottom to prevent slippage and keep the foot pedal in the correct position, and it has slots that accommodate different gauge diameters for the cords going to and from the pedals. The result is it decreases breaks in sterile technique when a pedal moves and has to be re-positioned, it significantly reduces incorrect pedal activation, and it makes the pedals much easier to locate when they are needed. The design covered by this patent also features slots for the electrical cords to prevent tangling, it maintains pedals in a predictable order for each user but enables pedals to be easily customized as needed, and allows pedals to be more easily cleaned between procedures.

U.S. Patent No. 11,134,775 for a “Pedal organizer and related system” would enable any manufacturer of multi-control surgical equipment systems to add a new level of controls and convenience for the surgeons using their equipment. Foot pedals are also used in industrial and commercial applications, and the same benefits apply to those industries.

Non-Radiation/Non-Chemotherapy Cancer Treatment (Elbe): International Patent Portfolio

Laying siege to a city and starving its citizens into surrender has been an effective military strategy for centuries. The Romans laid siege to Tyre in 332 BC, and the Germans laid siege to Leningrad in 1941 AD. The enemy surrounds a city, cuts it off the from the outside world, and starves its residents into submission and surrender. It is an effective, but brutal, strategy. This portfolio takes a similar approach to a brutal enemy – cancer. This international patent portfolio covers technology for selectively cutting off red blood cell flow to a tumor, starving the tumor of the nutrition it needs to survive and grow. The result is that the cancer is significantly slowed down – i.e., goes into remission – or it dies from lack of nutrition. Micro devices are injected into blood vessel(s) upstream of the tumor, and they occlude blood flow as directed by processors.

This portfolio creates a comprehensive cancer treatment that also includes a self-correcting RFI system that enables microbots to measure their position in a human body with micron-level precision while correcting in real-time for signal aberrations as the radio waves pass through the body. Additionally, a 3D ultrasonic imaging system provides high-contrast imaging via a digital synthetic aperture. This is an entirely new approach to medical imaging that eliminates the need for exposing patients to ionising radiation and allows a patient to move around freely during a scan.

Patent Portfolio

This portfolio will enable a medical device manufacturer to bring to market a highly effective cancer treatment technology that avoids the unfortunate side effects of radiation and chemotherapy.

Infection-Prevention Bandage-Swab Kit (Khan): U.S. Patent No. 8,240,472

The biggest single risk in treating a wound is infection. Everything that comes in touch with the wound has to be 100% sterile, and that is not always easy nor practical. When a treatment has to be applied to the wound, it is often done with a swab. The problem often is that the swab comes in touch with different surfaces and objects on its way from its sterile packaging to the wound. And that creates a source of infection. Not good.

This patent tackles that issue head-on, and – like so many patents – the invention is brilliantly simple. Both a sterile bandage and a sterile swab are packaged together in a two-compartment sealed kit. The sterile swab is removed from its sterile compartment and immediately used to apply treatment to the wound before it can touch any foreign object or it comes in contact with any surfaces. Then the sterile bandage is removed from the second sterile compartment and applied to the wound. So, both the swab and the bandage remain 100% sterile, significantly reducing the risk of infection. The container holding the swab and bandage can also contain an antibacterial agent, so the swab and bandage are ready-to-use. Quick and proper attention to a wound will speed healing and reduce scarring.

U.S. Patent No. 8,240,472 for a “Combination bandage and wound treatment system” would enable any supplier of medical products to offer an affordable, practical, and totally sterile would-care solution! It can be offered as an over-the-counter product for consumers, a product for medical professionals at hospitals and other medical facilities, a wound-treatment kit to take camping, fishing, or hunting, or as a component in first-aid kits.

Blood Clot Prevention Device (Khan): U.S. Patent No. 8,579,841

Blood clotting or coagulation is an important human process that enables blood to dry and form a protective covering over wounds. However, when blood clots form in the arteries – known as thrombosis – it becomes a serious health hazard. When clots collect in the deep veins in the legs or arms – a condition known as venous thromboembolism or deep vein thrombosis (DVT) – those clots can make their way to the heart, lungs, or brain and result in a stroke or death. As the U.S. population ages, deep vein thrombosis will become an increasingly more serious medical condition.

This patent covers a pressure cuff that contains bladders that are arranged in succession down the arm or leg of a user. An air compressor inflates the bladders, and a control module sequentially opens valves in the bladders to provide pressure in succession along the arm or leg of the patient. Additionally, tubes equalize pressure between bladders before exhausting air from a previously pressurized bladder to allow for increased patterns of bladder pressure. Pressure levels and bladder dwell times may be adjusted by the user or his or her physician, or can be based on predetermined settings. The device can also provide electrical stimulation, pulsations, heating, and cooling to increase blood flow and totally eliminate – or substantially reduce – clotting in the limbs.

U.S. Patent No. 8,579,841 for a “Blood clot prevention device” can be used to create a highly effective, non-drug, no-side-effects treatment for blood clotting in the arms and legs. This patent would be a strategic acquisition for any medical product manufacturer.

Medication Dispenser (Mauk): U.S. Patent No. 7,584,849

As America ages, a larger and larger portion of the population needs to take one or more prescription drugs on a regular basis. In fact, 85% of Americans over 60 take at least one prescription drug once a day. In addition to this, many younger, healthier Americans take vitamins and supplements on a regular basis. The challenge for both groups is keeping track of what drug or vitamin or supplement has and has not been taken each day.

This patent creates a tool for those who take drugs, vitamins, and/or supplements to make sure that no dosage is missed and the user does not double-dose. The device has adjustable slots that hold the bottles of medications, vitamins, or supplements, and a grid of pill dispensers, four (Morning, Noon, Evening, and Bedtime) for each day of the week for a total of 28. The user or caregiver fills each dispenser slot once a week with the pills or capsules to be taken at each time of the day. The unit includes an electronic display that shows what time of day it is. If a dispenser slot is empty, that means the user took those pills. If there are still pills in the slot, he or she forgot, and needs to take them. It also includes a slide-out drawer that holds a record of the patient’s prescriptions and dosages.

This invention insures that the user takes the medicines prescribed for him or her, along with the vitamins and supplements the user is taking, as prescribed. It eliminates the user – often an older person with diminished mental acuity – from both forgetting to take his or her medicine and accidentally double-dosing. U.S. Patent No. 7,584,849 for a “Home medication station” would enable a supplier of healthcare products to offer a highly useful product that purchasers will use and appreciate.

Specialized Skin Exfoliation (Perez): U.S. Patent No. 8,585,621

The skin is the largest organ in the human body. The outer layer of skin is continually dying and being replaced by new skin that replaces it. When a person gets a tan, that tan is a layer of darker, dead skin. Elbows, however, create a special problem. Dead skin builds up on the elbows, causing them to get darker and darker, creating a condition known as “Dark Elbows.” While Dark Elbows are not a health hazard, they can be very unattractive. This patent creates a device that specifically addresses Dark Elbows and other specialized skin exfoliation needs.

This patent creates a tabletop or floor-based skin exfoliation device that is enclosed in a housing. The user turns it on and places his or her elbows on the top surface of the device. The vibrating abrasive surface gently cleans away the dead skin from the elbows, eliminating Dark Elbows, and leaving a consistent skin tone on the user’s arms. The unit can also be placed on the floor, and the user can place his or her feet on the device to remove dead skin from the heels and soles of the feet. For the treatment of Dark Elbows, and for exfoliating feet, this device is clearly superior to the current generation of handheld exfoliation devices that are on the market.

U.S. Patent No. 8,585,621 for a “Skin exfoliation apparatus” would be a strategic acquisition for any manufacturer of exfoliation products looking to expand its product offerings, or for any medical device manufacturer seeking to expand into the huge exfoliation market with a unique, patent-protected product.

Laminitis Treatment for Horses (Medergo): U.S. Patent No. 8,465,444 and European Patent Application

Horses are smart, affectionate, and incredibly loyal. It is a shame that hundreds of horses a year have to be euthanized because they suffer from laminitis - an inflammation of the soft tissue structures that attach the coffin or pedal bone of the foot to the hoof wall known as “laminae” – and they cannot be effectively treated. As laminitis (also known as “founder”) progresses, a horse can eventually not stand or walk, and the horse must be put down. Such a tragedy for such wonderful animals that have been bred and raised and cared for by humankind for centuries.

This portfolio creates an effective and affordable treatment for laminitis. The invention is a garment wrap that is secured to the animal's leg and includes inflatable chambers that engage critical points on the horse’s leg and hoof. The inflatable chambers are pressurized in a sequence that prevents backflow from a more proximal point on the animal's leg to a more distal point on the leg. A boot with an inner sole pad is also used during the therapy procedure and afterwards, and the inner sole pad can be used to administer medications as well as for an iontophoresis procedure. The boot assists with other treatments to increase circulation to aid healing in the hoof by increasing blood flow.

Wounds and problems of the legs of horses are the result of poor circulation along with lymphedema, venous stasis, trauma, cellulitis, and postsurgical swelling. In addition to treatment of laminitis, this invention can be used as a rehabilitative device as well as a conditioning tool for animals that are recuperating from other conditions. This treatment for horses was developed from a similar method used with great success on thousands of human patients with circulatory issues.

This portfolio includes U.S. Patent No. 8,465,444 and European Patent Application 2983634 for “Laminitis treatment system and method.” The acquirer of this portfolio can create the first effective and affordable – as well as life-saving – treatment for laminitis in hoofed animals with patent protection on two continents.

Next-Generation Electrotherapy (Li): U.S. Patent No. 10,471,253

The earth is a huge magnet with a positive and negative pole. All animals on the earth carry that same positive and negative magnetic charge, including all humans. Electrotherapy – the application of low-voltage electric current through the human body – has been proven to treat many conditions, from relieving pain to healing wounds, by improving the electromagnetic balance in the body. Also known as electromagnetic therapy, the treatment of diseases and afflictions via electrotherapy goes back over 200 years. The first recorded use of electrotherapy was by Johann Gottlob Krüger in 1743. John Wesley, an Anglican clergyman and the founder of the Methodist Church, was a proponent of electrotherapy.

This patent takes electrotherapy to the next level by creating a device for applying a carefully controlled and regulated flow of electrons to the human body in a field between positive and negative electrodes. It includes an electric field detector that measures and transmits data about the strength of the actual electric field back to the operator. A microprocessor receives this data and compares it against the parameters of a wellness-promoting electric field so the pulse-width modulator is operating at optimal performance. The wellness of a patient is enhanced by ensuring that the positive electrode is in correct approximation to a positive location on the patient and the negative electrode is in correct approximation to a negative location on the patient. A flow of electrons at the right strength has been documented to treat such maladies as depression, muscle pain, constipation, sinus infection, low blood pressure, nausea and vomiting, insomnia, infertility, asthma and tinnitus, to name just a few.

U.S. Patent No. 10,471,253 for a “System and method to modulate an electric field in an environment” would enable a medical device manufacturer to introduce a product for those seeking treatment of their disease or condition via a controlled electrical field.

Bacteria Biosensor Detection System (Edmonson): Two U.S. Patents, Canadian Patent and Prototypes

When examining a patient, and a bacterial infection is suspected, it is important for the physician to know quickly if live bacteria are present. Farmers need to know if bacteria are present that can be a threat to their crops and feedstocks. Food processing plants need to be able to quickly detect if bacteria are present in food processing, handling and storage equipment and locations. The invention covered by this portfolio addresses exactly that need by creating a low-cost, portable, easy-to-use bacteria biosensor that can detect the presence of live bacteria in real time.

Patent No.Title
US 7,651,843Acoustic wave biosensor for the detection and identification of characteristic signaling molecules in a biological medium
US 8,420,382Acoustic wave biosensor for the detection and identification of characteristic signaling molecules in a biological medium
CA 2520812Method and system for archiving biomedical data generated by a data collection device

This portfolio covers an invention that detects, isolates and characterizes the QS signals made by both Gram Positive and Gram Negative bacteria. It creates a low-cost, small and portable testing unit for at-home, in-clinic, in-facility or in-field use. It can detect bacteria in either vapor or liquid, as a breathalyzer-type bacteria monitor, or a unit that can be placed in a location to sample the surrounding air for bacterial-signaling molecules.

In addition to the two U.S. Patents and the Canadian Patent, this portfolio includes working prototypes, so the company that acquires this property will be able to go to market very quickly with a bacteria biosensor that is cheaper than current products, produces results faster, and can be used in many more locations and applications!

ID/Medical Data/Alerts System (Solomon Systems): Five U.S. Patents

What happens when a person needs medical attention, but that person is unconscious? Or seriously injured or disabled? Or cannot speak? Or is disoriented and not totally lucid? It is difficult to provide medical care without at least some basic health information about that person. This challenge – an increasingly common occurrence – is what the invention covered by this portfolio addresses.

This portfolio covers a health-record provisioning system with multiple advantages:

The portfolio includes U.S. Patent Nos. 8,181,862, 8,485,439, 8,833,649, 9,165,335 and 9,390,231 titled "System for Providing Identification and Information, and for Scheduling Alerts." Included in the portfolio are two Chinese Patent Applications and a PCT Application. Technology covered by this portfolio has the capabilities to save lives, and it would give a critical competitive advantage to a healthcare provider, electronic device OEM or smartcard provider.

Patent Brokerage Prospectus: Contact [email protected] to receive an analysis of each portfolio that includes:

We offer patents in these technologies: